Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa(University of Oxford), Juthathip Mongkolsapaya(Centre for Human Genetics), Jose Slon-Campos(Centre for Human Genetics), Neil G. Paterson(Diamond Light Source), Aekkachai Tuekprakhon(University of Birmingham), Guido C. Paesen(Centre for Human Genetics), William James(University of Oxford), Helen M. E. Duyvesteyn(Centre for Human Genetics), Naomi S. Coombes(Public Health England), Sue Charlton(Environment Agency), Holly E. Humphries(Public Health England), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), Elizabeth Clutterbuck(University of Oxford), Thomas S. Walter(Centre for Human Genetics), Helen M. Ginn(Instruct-ERIC), Rungtiwa Nutalai(Centre for Human Genetics), Christina Dold(University of Oxford), Donal Skelly(John Radcliffe Hospital), Daming Zhou(Centre for Human Genetics), Alexander J. Mentzer(Centre for Human Genetics), César López‐Camacho(Centre for Human Genetics), Julian C. Knight(Chinese Academy of Medical Sciences & Peking Union Medical College), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Sheila Lumley(University of Oxford), Andrew J. Pollard(University of Oxford), Alex Sienkiewicz(Public Health England), Sagida Bibi(University of Oxford), Nick Gent, Miles W. Carroll(Institute of Human Genetics), Natalie Baker, Yuguang Zhao(University of Oxford), Sandra Belij‐Rammerstorfer(University of Oxford), Tao Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Elizabeth E. Fry(University of Oxford), Bassam Hallis(Public Health England), Susanna Dunachie(Mahidol University), Amy Flaxman(University of Oxford), Kevin R. Bewley(UK Health Security Agency), Derrick W. Crook(John Radcliffe Hospital), Imam Shaik(Public Health England), Beibei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chang Liu(Paul Scherrer Institute), Mark A. Williams(Diamond Light Source), David R. Hall(Diamond Light Source), Robert H. Levin(Worthing Hospital), Wanwisa Dejnirattisai(University of Oxford), Teresa Lambe(Science Oxford), Kerry Godwin(Public Health England), Mustapha Bittaye(University of Oxford)
Cited by 529
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k